KPTI
Price
$4.54
Change
-$0.12 (-2.58%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
40.18M
MGNX
Price
$1.32
Change
-$0.01 (-0.75%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
84.54M
48 days until earnings call
Interact to see
Advertisement

KPTI vs MGNX

Header iconKPTI vs MGNX Comparison
Open Charts KPTI vs MGNXBanner chart's image
Karyopharm Therapeutics
Price$4.54
Change-$0.12 (-2.58%)
Volume$200
Capitalization40.18M
MacroGenics
Price$1.32
Change-$0.01 (-0.75%)
Volume$18.29K
Capitalization84.54M
KPTI vs MGNX Comparison Chart in %
Loading...
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KPTI vs. MGNX commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPTI is a Buy and MGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (KPTI: $4.65 vs. MGNX: $1.34)
Brand notoriety: KPTI and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KPTI: 61% vs. MGNX: 67%
Market capitalization -- KPTI: $40.18M vs. MGNX: $84.54M
KPTI [@Biotechnology] is valued at $40.18M. MGNX’s [@Biotechnology] market capitalization is $84.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KPTI’s FA Score shows that 0 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • KPTI’s FA Score: 0 green, 5 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, both KPTI and MGNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KPTI’s TA Score shows that 5 TA indicator(s) are bullish while MGNX’s TA Score has 2 bullish TA indicator(s).

  • KPTI’s TA Score: 5 bullish, 4 bearish.
  • MGNX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, KPTI is a better buy in the short-term than MGNX.

Price Growth

KPTI (@Biotechnology) experienced а +6.53% price change this week, while MGNX (@Biotechnology) price change was -2.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

KPTI is expected to report earnings on May 13, 2025.

MGNX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($84.5M) has a higher market cap than KPTI($40.2M). KPTI YTD gains are higher at: -54.162 vs. MGNX (-58.769). KPTI has higher annual earnings (EBITDA): -19.64M vs. MGNX (-47.33M). MGNX has more cash in the bank: 154M vs. KPTI (69.9M). MGNX has less debt than KPTI: MGNX (37.5M) vs KPTI (187M). MGNX has higher revenues than KPTI: MGNX (152M) vs KPTI (142M).
KPTIMGNXKPTI / MGNX
Capitalization40.2M84.5M48%
EBITDA-19.64M-47.33M41%
Gain YTD-54.162-58.76992%
P/E RatioN/AN/A-
Revenue142M152M93%
Total Cash69.9M154M45%
Total Debt187M37.5M499%
FUNDAMENTALS RATINGS
KPTI vs MGNX: Fundamental Ratings
KPTI
MGNX
OUTLOOK RATING
1..100
5486
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9193
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPTI's Valuation (50) in the Biotechnology industry is in the same range as MGNX (50). This means that KPTI’s stock grew similarly to MGNX’s over the last 12 months.

KPTI's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MGNX (100). This means that KPTI’s stock grew similarly to MGNX’s over the last 12 months.

KPTI's SMR Rating (100) in the Biotechnology industry is in the same range as MGNX (100). This means that KPTI’s stock grew similarly to MGNX’s over the last 12 months.

KPTI's Price Growth Rating (91) in the Biotechnology industry is in the same range as MGNX (93). This means that KPTI’s stock grew similarly to MGNX’s over the last 12 months.

MGNX's P/E Growth Rating (95) in the Biotechnology industry is in the same range as KPTI (100). This means that MGNX’s stock grew similarly to KPTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KPTIMGNX
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 23 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLRTF0.070.01
+11.08%
HILLCREST ENERGY TECHNOLOGIES LTD.
DNPLY7.320.10
+1.35%
Dai Nippon Printing Co. Ltd.
POAHY3.840.05
+1.32%
Porsche Automobile Holding SE
FGOVF0.950.01
+0.80%
Freegold Ventures Ltd.
RBGLY13.850.05
+0.36%
Reckitt Benckiser Group Plc.

KPTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPTI has been loosely correlated with MGNX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if KPTI jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPTI
1D Price
Change %
KPTI100%
+7.39%
MGNX - KPTI
38%
Loosely correlated
+1.52%
ARRY - KPTI
35%
Loosely correlated
-13.80%
XNCR - KPTI
35%
Loosely correlated
-1.66%
NTLA - KPTI
35%
Loosely correlated
+3.68%
FATE - KPTI
35%
Loosely correlated
+2.63%
More

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with CRBU. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+1.52%
CRBU - MGNX
52%
Loosely correlated
+6.82%
XNCR - MGNX
50%
Loosely correlated
-1.66%
BEAM - MGNX
46%
Loosely correlated
+2.63%
RGNX - MGNX
46%
Loosely correlated
+8.91%
FATE - MGNX
46%
Loosely correlated
+2.63%
More